BI 3706674

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 3706674, covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus [Phase 1]

See pricing